spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

High performance range of insulated shipping systems

Laminar Medica


Laminar Medica’s Chilltherm® Global range of high performance insulated shipping systems, from 4 to 1130 litres product volume, are designed to offer optimal thermal protection for pharmaceutical products when exposed to extreme climates from -20°C to +40°C.

These shipping systems are pre-qualified to maintain payload integrity between +2°C and +8°C for transit durations of up to 120 hours. Real live data profiles have been used to give customers confidence that the quality and efficacy of their payloads will not be compromised during even the most demanding external temperatures. Cross hemisphere profile testing makes it ideal for clients making transcontinental shipments.

With only three sizes of cool packs used across the range and a common bill of materials for summer and winter pack outs the impact to warehousing and handling is minimised.

phone 44 (0)14 4282 8664
email enquiries@laminarmedica.co.uk
web www.laminarmedica.com
email Unit 4 Tring Industrial Estate, Icknield Way, Tring, Hertfordshire, HP23 4JX
 
Print this page
Send to a friend
   
spacer
News and Press Releases

CPhI 2014 Expert Industry Annual Report: Part iii

Experts predict slow progress in government and regulatory proposals to tighten supply chain, argue patents should only be awarded for working prototypes and foresee two-tier outsourcing market
More info >>


White Papers

RUNNING SMARTER TRIALS WITH DATA-DRIVEN MONITORING

PAREXEL

Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm. Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little. Now, after several years of industry discussion and recent industry collaboration1, there’s solidifying consensus that adoption of data-driven monitoring can substantially improve study quality, safety, and also reduce monitoring costs, which today account for 15-30% of total study costs. Data-driven monitoring represents a major departure from traditional monitoring in which clinical research associates (CRA) typically visit sites on a fixed schedule. Instead, data-driven monitoring leverages eClinical technology (EDC, CTMS, RTSM) to turn monitoring into a flexible, responsive, team-based activity.
More info >>

Industry Events

Advances in Cell Based Assays

11-12 November 2014, The Marriott Regents Park Hotel, London UK

SMi Group invites you to attend the market leading cell based event, Advances in Cell Based Assays, taking place on 11th & 12th November in Central London.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement